Get started
Author

Josep M. Domingo Domenech

Observed names: J Domingo-Domenech, J. Domingo-Domenech, J. Domingo-Domènech, J. Domingo-Doménech, Josep Doming-Domenech, Josep Domingo Domenech, Josep Domingo-Domenech, Josep Domingo-Domènech, Josep Domingo-Doménech, Josep Domingo‐Domenech
Observed institutions: Mount Sinai Health System, Mayo Clinic, Thomas Jefferson University, Columbia University Irving Medical Center, Sidney Kimmel Cancer Center, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Hospital Del Mar, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Herbert Irving Comprehensive Cancer Center, Mayo Clinic Comprehensive Cancer Center (Minnesota), Tisch Cancer Institute, Albany Medical College, Takeda Oncology (United States), Universitat de Barcelona, Columbia University, Icahn School of Medicine at Mount Sinai
ORCID: 0000-0002-7870-7511
Observed ORCID: 0000-0002-7870-7511
OpenAlex ID: A5089881663
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
2012 · Josep Domingo-Domenech, Samuel J. Vidal, et al. · Cancer Cell · 416
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
2018 · Li Wang, Abdel Saci, et al. · Nature Communications · 312
PDF
Molecular pathways of urothelial development and bladder tumorigenesis
2010 · Mireia Castillo-Martin, Josep Domingo-Domenech, et al. · Urologic Oncology Seminars and Original Investigations · 251
Targeting cancer stem cells to suppress acquired chemotherapy resistance
2013 · S J Vidal, V Rodriguez-Bravo, et al. · Oncogene · 242
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
2015 · Victoria Tovar, Helena Cornella, et al. · Gut · 206
Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity
2006 · Josep Domingo-Domenech, Cristina Oliva, et al. · Clinical Cancer Research · 166
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import
2018 · Veronica Rodriguez-Bravo, Raffaella Pippa, et al. · Cell · 152
PDF
A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
2015 · Samuel J. Vidal, Veronica Rodriguez-Bravo, et al. · Cancer Cell · 145
Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression
2011 · Orit Karni-Schmidt, Mireia Castillo-Martin, et al. · American Journal Of Pathology · 142
PDF
The role of GATA2 in lethal prostate cancer aggressiveness
2016 · Veronica Rodriguez-Bravo, Marc Carceles-Cordon, et al. · Nature Reviews Urology · 128
Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse
2005 · J Domingo-Domenech, B Mellado, et al. · British Journal of Cancer · 115
PDF
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
2017 · Matthew D. Galsky, Huan Wang, et al. · European Urology · 113
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
2006 · Jordi Codony-Servat, Maria A. Tapia, et al. · Molecular Cancer Therapeutics · 104
PDF
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease
2021 · Amy C. Mandigo, Wei Yuan, et al. · Cancer Discovery · 94
Cellular rewiring in lethal prostate cancer: the architect of drug resistance
2020 · Marc Carceles-Cordon, W. Kevin Kelly, et al. · Nature Reviews Urology · 89
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
2021 · Katsutoshi Sato, Amol A. Padgaonkar, et al. · Nature Communications · 67
PDF
Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
2015 · Estrelania S. Williams, Veronica Rodriguez-Bravo, et al. · Journal of Visualized Experiments · 59
PDF
Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cells
2020 · Fabio Quaglia, Shiv Ram Krishn, et al. · Journal of Extracellular Vesicles · 45
PDF
Inactivation of NF-κB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells
2007 · Josep Domingo-Domènech, Raffaella Pippa, et al. · Breast Cancer Research and Treatment · 43
Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool
2011 · Leonardo Oliveira Reis, Josep Maria Gaya Sopena, et al. · Acta Cirúrgica Brasileira · 42
PDF
Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients With Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy
2011 · Matthew S. Wosnitzer, Josep Domingo-Domenech, et al. · The Journal of Urology · 40
Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
2016 · Juan J. Grau, Ricard Mesía, et al. · Oncology · 32
A Common MicroRNA Signature Consisting of miR-133a, miR-139-3p, and miR-142-3p Clusters Bladder Carcinoma in Situ with Normal Umbrella Cells
2013 · Angela Y. Jia, Mireia Castillo-Martin, et al. · American Journal Of Pathology · 29
PDF
Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer
2007 · C. Conill, J. Marruecos, et al. · Clinical & Translational Oncology · 29
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer
2023 · Brittiny Dhital, Sandra Santasusagna, et al. · Cell Reports Medicine · 26
Works count: 98
Citation count: 3,418
H-index: 25
I10-index: 40
Year
Topic
Type